KEX:NYSEKirby Corporation Analysis
Data as of 2026-08-26 - not real-time
$137.64
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
Kirby Corporation is priced at $137.64, and its moving averages give no clean directional read — the structure is neutral. The last 30 days have lost 5.1%. Momentum indicators put RSI at 49.0 (neutral) with MACD reading bullish. The recent range runs from support at $128.91 up to resistance at $142.75.
Valuation screens as undervalued: a P/E of 21.3 sits below the sector average of 29.6. Consensus targets land 20.7% above where the shares trade now. Revenue is growing at 7.8% on a 10.2% profit margin.
Risk comes out at 4 of a possible 10, a moderate reading. With 30-day volatility of 36.2%, a beta of 0.59 and a maximum drawdown of 18.6%, position sizing matters here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
The horizons line up on buy — conviction 7 out of 10.
Valuation screens as undervalued: a P/E of 21.3 sits below the sector average of 29.6. Consensus targets land 20.7% above where the shares trade now. Revenue is growing at 7.8% on a 10.2% profit margin.
Risk comes out at 4 of a possible 10, a moderate reading. With 30-day volatility of 36.2%, a beta of 0.59 and a maximum drawdown of 18.6%, position sizing matters here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
The horizons line up on buy — conviction 7 out of 10.
Top Market Events
Seeking Alpha27dKirby Corporation KEX Q2 2026 Earnings Call TranscriptGood day, and thank you for standing by.Kirby stock has delivered a strong 132.6% return over the past 5 years, yet the latest checks suggest a more nuanced...
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 6/10
Key Factors
- Trading above the 200-day average of 131.01
- MACD momentum is positive
- 30-day price change of -5.1%
Medium Term
1–3 yearsPositive
Model confidence: 6/10
Key Factors
- P/E of 21.3 versus sector average of 29.6
- Trading above the 200-day average of 131.01
- Analyst targets imply +20.7% versus the current price
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- P/E of 21.3 versus sector average of 29.6
- Analyst targets imply +20.7% versus the current price
- Price-to-book of 2.12
Key Metrics & Analysis
Financial Health
Revenue Growth7.80%
Profit Margin10.18%
P/E Ratio21.3
ROE10.41%
ROA5.13%
Debt/Equity35.62
P/B Ratio2.1
Op. Cash Flow$709.7M
Free Cash Flow$347.2M
Industry P/E29.6
Technical Analysis
TrendNeutral
RSI49.0
Support$128.91
Resistance$142.75
MA 20$135.26
MA 50$138.77
MA 200$131.01
MACDBullish
VolumeDecreasing
Fear & Greed Index93.38
Valuation
Fair Value$94.50
Target Price$166.17
Upside/Downside20.73%
GradeUndervalued
TypeBlend
Risk Assessment
Beta0.59
Volatility36.22%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.